stockrow
Saturday 7 November 2026
Export HUM’s income statement to Excel — free account
Humana Inc.
HUM Healthcare Healthcare Plans
Humana Inc.’s revenue for fiscal 2025 (year ended December 2025) was $129.7 billion, up 10.1% from fiscal 2024.
- Revenue
- +26.1%
- EPS
- −16.7%
- Free cash flow
- +158.7%
- Total debt
- −0.82%
Quarter to September 2026, against a year earlier
433.74
21.95
+5.33%
Follow HUM
Alert me
| Sep '26 From the 10-Q filed 6 Nov | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
36.76 | 37.30 | 18.47 | 26.03 |
+8 more quarters Free account |
P/S ratio |
0.30 | 0.33 | 0.15 | 0.24 | |
P/FCF ratio |
14.48 | 24.18 | 16.11 | 77.52 | |
P/Operating CF |
21.19 | 24.26 | 16.64 | (18.68) | |
P/B ratio |
2.43 | 2.47 | 1.12 | 1.74 | |
Price to Tangible BV |
5.49 | 5.42 | 2.56 | 3.83 | |
EV/Sales |
0.22 | 0.26 | 0.09 | 0.18 | |
EV/EBITDA |
10.57 | 10.92 | 3.97 | 6.77 | |
EV/Operating CF |
8.90 | 14.99 | 6.99 | 25.94 | |
EV/FCF |
10.50 | 19.30 | 9.96 | 60.04 | |
Quick Ratio |
1.16 | 1.29 | 1.26 | 1.42 | |
Current Ratio |
1.65 | 1.74 | 1.77 | 2.00 | |
Net Debt/EBITDA |
(48.11) | (6.22) | (4.09) | 12.27 | |
Debt/Assets |
21.83% | 24.91% | 25.31% | 25.29% | |
Debt/Equity |
0.66 | 0.74 | 0.75 | 0.70 | |
Asset Turnover |
2.88 | 2.71 | 2.58 | 2.72 | |
Operating CF/Net income |
13.35 | 2.83 | 1.06 | 2.08 | |
Capex/Depreciation |
0.00 | (0.70) | (0.62) | (0.92) | |
Interest Coverage |
0.35 | 6.90 | 9.09 | (5.53) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.18 | 0.18 | 0.19 | 0.20 | |
Share Based Compensation of Revenue |
0.16% | 0.16% | 0.13% | 0.15% | |
Graham Net Nets |
0.03 | 0.05 | 0.07 | 0.05 | |
Graham Number |
191.66 | 196.14 | 180.94 | 180.56 | |
Earnings Yield |
2.72% | 2.68% | 5.42% | 3.84% | |
Free Cash Flow Yield |
6.90% | 4.13% | 6.21% | 1.29% | |
Revenue per Share |
342.69 | 340.37 | 329.49 | 269.94 | |
Operating CF per Share |
18.01 | 16.37 | 10.42 | (13.71) | |
Capex per Share |
0.00 | (1.10) | (1.01) | (1.49) | |
Free Cash Flow per Share |
18.01 | 15.27 | 9.42 | (15.20) | |
Cash per Share |
209.08 | 198.82 | 182.54 | 165.23 | |
Shareholders Equity per Share |
157.28 | 160.55 | 154.95 | 147.25 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
157.28 | 160.55 | 154.95 | 147.25 | |
Free Cash Flow |
2,163.00 | 1,834.00 | 1,133.00 | (1,831.00) | |
Working Capital |
15,557.00 | 17,079.00 | 16,573.00 | 16,387.00 | |
Capital Expenditures |
— | (132.00) | (121.00) | (179.00) | |
Net Current Asset Value |
1,212.00 | 2,167.00 | 1,446.00 | 1,561.00 | |
EV/EBIT |
13.95 | 14.07 | 5.28 | 8.84 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.01 | |
Price to Operating Income |
19.25 | 17.62 | 8.54 | 11.41 | |
| Other line items | |||||
Average Receivables |
2,774.50 | 5,099.50 | 4,838.50 | 2,987.00 | |
Average Payables |
7,454.50 | 6,425.00 | 5,955.50 | 5,488.00 | |
Average Assets |
53,502.00 | 53,776.50 | 53,105.00 | 47,694.00 | |
Average Common Equity |
18,735.00 | 18,786.00 | 18,232.50 | 17,091.00 |
Columns are period end dates · fundamentals updated 6 Nov 2026